Phei-Lang Chang

Author PubWeight™ 42.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of the SF-36 quality of life scale to assess the effect of pelvic floor muscle exercise on aging males who received transurethral prostate surgery. Clin Interv Aging 2013 1.46
2 Bikunin loss in urine as useful marker for bladder carcinoma. J Urol 2010 1.45
3 Cardiac glycosides decrease prostate specific antigen expression by down-regulation of prostate derived Ets factor. J Urol 2010 1.41
4 Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients. J Proteome Res 2012 1.14
5 SNP-RFLPing: restriction enzyme mining for SNPs in genomes. BMC Genomics 2006 1.10
6 Discovery of novel bladder cancer biomarkers by comparative urine proteomics using iTRAQ technology. J Proteome Res 2010 1.10
7 L-Mimosine blocks cell proliferation via upregulation of B-cell translocation gene 2 and N-myc downstream regulated gene 1 in prostate carcinoma cells. Am J Physiol Cell Physiol 2011 1.00
8 Synchronous primary carcinomas of the bladder and prostate. Asian J Androl 2006 1.00
9 Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males. Clin Interv Aging 2013 0.94
10 Searching cell-secreted proteomes for potential urinary bladder tumor markers. Proteomics 2006 0.93
11 Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells. J Androl 2008 0.93
12 Odds ratio-based genetic algorithms for generating SNP barcodes of genotypes to predict disease susceptibility. OMICS 2008 0.92
13 Metallothionein 3: an androgen-upregulated gene enhances cell invasion and tumorigenesis of prostate carcinoma cells. Prostate 2013 0.91
14 Concurrent cisplatin, 5-fluorouracil, leucovorin, and radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys 2003 0.91
15 Evaluating the function of matriptase and N-acetylglucosaminyltransferase V in prostate cancer metastasis. Anticancer Res 2008 0.89
16 Triiodothyronine modulates cell proliferation of human prostatic carcinoma cells by downregulation of the B-cell translocation gene 2. Prostate 2008 0.89
17 The safety and efficacy of aspirin intake in photoselective vaporization laser treatment of benign prostate hyperplasia. Clin Interv Aging 2013 0.87
18 Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells. Int J Cancer 2011 0.87
19 Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells. J Mol Endocrinol 2012 0.86
20 Enterovesical fistula caused by a bladder squamous cell carcinoma. World J Gastroenterol 2009 0.86
21 Economic Evaluation Study (Cheer Compliant) Laser Prostatectomy for Benign Prostatic Hyperplasia: Outcomes and Cost-effectiveness. Medicine (Baltimore) 2016 0.86
22 Loupe-assisted high inguinal varicocelectomy for sub-fertile men with varicoceles. Chang Gung Med J 2003 0.86
23 Clinical outcome of primary small cell carcinoma of the urinary bladder. Onco Targets Ther 2013 0.85
24 Risk factors associated with transrectal ultrasound guided prostate needle biopsy in patients with prostate cancer. Chang Gung Med J 2009 0.85
25 p53 downregulates the gene expression of mitochondrial aconitase in human prostate carcinoma cells. Prostate 2011 0.84
26 Mechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells. Biomed Res Int 2013 0.84
27 Hypoxia upregulates the gene expression of mitochondrial aconitase in prostate carcinoma cells. J Mol Endocrinol 2013 0.84
28 Glycoprotein transmembrane nmb: an androgen-downregulated gene attenuates cell invasion and tumorigenesis in prostate carcinoma cells. Prostate 2012 0.84
29 SNP ID-info: SNP ID searching and visualization platform. OMICS 2008 0.83
30 Does adequate bladder cuff excision impact outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma. Chang Gung Med J 2011 0.83
31 Identifying the combination of the transcriptional regulatory sequences on prostate specific antigen and human glandular kallikrein genes. J Urol 2004 0.83
32 V-MitoSNP: visualization of human mitochondrial SNPs. BMC Bioinformatics 2006 0.82
33 Restriction enzyme mining for SNPs in genomes. Anticancer Res 2008 0.82
34 Down-regulation of matriptase by overexpression of bikunin attenuates cell invasion in prostate carcinoma cells. Anticancer Res 2008 0.82
35 Mechanisms by which interleukin-6 regulates prostate-specific antigen gene expression in prostate LNCaP carcinoma cells. J Androl 2010 0.82
36 Prostate specific antigen gene expression in androgen insensitive prostate carcinoma subculture cell line. Anticancer Res 2008 0.82
37 Web-based clinical pathway for reducing practice variations in radical prostatectomy. Chang Gung Med J 2009 0.81
38 Down-regulation of the prostate specific antigen promoter by p53 in human prostate cancer cells. J Urol 2004 0.80
39 The role of diuretic renography in the evaluation of obstructed hydronephrosis after pediatric pyeloplasty. Chang Gung Med J 2004 0.80
40 Correlation between the Gleason scores of needle biopsies and radical prostatectomy specimens. Chang Gung Med J 2003 0.78
41 The outcome of patients on dialysis with upper urinary tract transitional cell carcinoma. J Urol 2006 0.78
42 Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells. Mol Nutr Food Res 2011 0.78
43 Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China. Asian J Androl 2007 0.77
44 Zinc blocks gene expression of mitochondrial aconitase in human prostatic carcinoma cells. Int J Cancer 2006 0.77
45 Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients. Genes Chromosomes Cancer 2010 0.77
46 Can probability of genetic mutation be an indicator of clinical relevance? Genomics 2007 0.76
47 Using a Harmonic Scalpel "Drilling and Clamping" Method to Implement Zero Ischemic Robotic-assisted Partial Nephrectomy: An Observation Case Report Study. Medicine (Baltimore) 2016 0.75
48 Arterial bleeding in patients with intractable hematospermia and concomitant hematuria: a preliminary report. Urology 2006 0.75
49 Interstitial laser photocoagulation for treatment of benign prostatic hypertrophy: outcomes and cost effectiveness. Chang Gung Med J 2003 0.75
50 Absence of Epstein-Barr virus infection in squamous cell carcinoma of upper urinary tract and urinary bladder. Urology 2006 0.75
51 Combined surgery for intra-abdominal extra-urinary lesions in patients with renal and/or ureteral malignancies. Chang Gung Med J 2004 0.75
52 Divergent effect of liver X receptor agonists on prostate-specific antigen expression is dependent on androgen receptor in prostate carcinoma cells. Prostate 2015 0.75
53 Microsurgical vasectomy reversal: ten-years' experience in a single institute. Chang Gung Med J 2002 0.75
54 Manganese antagonizes iron blocking mitochondrial aconitase expression in human prostate carcinoma cells. Asian J Androl 2006 0.75